News
  • posted 12-12-2017

    MarkVCID at International Stroke Conference 2018

    On Jan 25, 2018, the AHA International Stroke Conference will feature the MarkVCID Consortium as a part of its 2 ½-day agenda covering over 1,500 presentations in 21 categories that emphasize basic, clinical and translational sciences.

    The panel discussion entitled, “Marking Vascular Cognitive Impairment: MarkVCID” will begin with an overview of the Consortium goals, science, and structure from MarkVCID Coordinating Center PI Steve Greenberg. The panel has invited Consortium PI’s Julie Schneider (Rush University) to discuss multimodal MRI biomarkers and Donna Wilcock (University of Kentucky) to discuss fluid-based biomarkers of cerebral small vessel disease. Participants will have the opportunity to learn about the challenges and successes of developing shared protocols, validating across sites, and achieving multicenter reliability for the discovery of clinical trial-ready biomarkers.

    The panel discussion will be moderated by NINDS Program Director and NIH Lead Roderick A. Corriveau and Johns Hopkins Bloomberg School of Public Health Faculty Rebecca Gottesman. Sharing a perspective from outside the Consortium, Institute for Stroke and Dementia Research Director Martin Dichgans will speak about international biomarker programs and collaboration opportunities.

    When: Jan 25, 2018, 3:30PM-5PM PST
    Location: Los Angeles Convention Center
    For more information about ISC, click here.

  • posted 03-10-2017

    MarkVCID Kickoff Meeting

    The MarkVCID Consortium held it's first Annual Meeting on February 20-21, 2017 in Houston, Texas just prior to the International Stroke Conference.

Copyright © 2017. All rights reserved.